about
The role of microRNA in head and neck cancer: current knowledge and perspectivesCerebellar glioblastoma multiforme in an adult woman.Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.Dosimetric predictors of acute hematologic toxicity during concurrent intensity-modulated radiotherapy and chemotherapy for anal cancer.The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?The Evolving Role of Radiotherapy in Early Stage Hodgkin's Lymphoma.Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational studyContouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group.Hospital admission of cancer patients: avoidable practice or necessary care?Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current EvidenceTechnical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.Non-surgical organ preservation strategies for locally advanced laryngeal tumors: what is the Italian attitude? Results of a national survey on behalf of AIRO and AIOM.Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's Lymphoma: dosimetric comparison and clinical considerationsDoes TomoDirect 3DCRT represent a suitable option for post-operative whole breast irradiation? A hypothesis-generating pilot study.Treatment options in skeletal localizations of hairy cell leukemia: a systematic review on the role of radiation therapy.A strategy for young members within national radiation oncology societies: the Italian experience (AIRO Giovani group).Swallowing dysfunction in head and neck cancer patients treated by radiotherapy: review and recommendations of the supportive task group of the Italian Association of Radiation Oncology.Is the combination of Cetuximab with chemo-radiotherapy regimens worthwhile in the treatment of locally advanced head and neck cancer? A review of current evidence.New concepts and insights into the role of radiation therapy in extracranial metastatic disease.Management of 'in-field' skin toxicity in head and neck cancer patients treated with combined cetuximab and radiotherapy.From radiobiology to technology: what is changing in radiotherapy for prostate cancer.Role of modern radiation therapy in early stage Hodgkin's lymphoma: A young radiation oncologists' perspective.Is stereotactic ablative radiotherapy an alternative to surgery in operable stage I non-small cell lung cancer?Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era.A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer.Stereotactic ablative radiotherapy in the treatment of hepatocellular carcinoma >3 cm.Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology.Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.Palliative radiotherapy for painful bone metastases from solid tumors delivered with static ports of tomotherapy (TomoDirect): feasibility and clinical results.Image-guided IMRT with simultaneous integrated boost as per RTOG 0529 for the treatment of anal cancer.Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways.Squamous cell carcinoma of the prostate: long-term survival after combined chemo-radiation.Leptomeningeal metastasis from prostate cancer.Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series.Active treatment given in the last weeks of life: poor quality cancer care or justifiable behavior?Relationships between bladder dose-volume/surface histograms and acute urinary toxicity after radiotherapy for prostate cancer.Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer.
P50
Q26851256-24E2F0A6-6571-4999-87DA-20C5424CAA12Q30839581-BA4585DE-065A-4F57-ADE2-11695700DC5DQ33422634-DBFA060C-CC54-45A0-A36B-7462435A4C63Q33431168-3172A483-74EC-49EF-A554-BCC4842D0052Q33442985-9C843327-9710-4917-A48C-20E5574DCCAAQ33778385-6656541D-F3FA-4A21-8DAC-F1A37246D44BQ34989365-BAB6630E-8CC1-4FDD-9836-9F7FCE4DD8C4Q35203444-6CE2B974-9BDC-4DA7-B3CF-855B7A4BD99CQ35219948-BC24A30A-4E0C-4E2F-9FC9-5DFED81344E1Q35399580-20A69CA0-8298-4C63-A294-AF00B5D0B924Q35534813-FBD7388F-8C55-4B24-BD61-CA098903C6B3Q35766501-7E1B9D3E-ADBF-42B7-90B5-E3BFFD161127Q36049570-6154EF21-5757-4AFB-AA8E-E6105D11A6F2Q36412607-6E6A3E72-6E36-442A-A0F1-5AF96DA7CCC9Q36541594-A76698FA-0A85-46B3-898D-B29AD704F739Q36892569-3D723CB3-C8ED-4E8A-BA38-1D39483460C8Q37453969-1670593F-6AE6-43D9-8131-F5BEFCD50924Q38006297-FC5D50EB-510D-4E2D-AFDC-C83374AD3070Q38022410-639F3842-A572-4A3F-B48F-9656080ABADEQ38153442-E0D91870-BA28-408D-A850-1AFCC4EFE622Q38160146-A5DFAC0C-DFD0-4D71-A694-2947EDB2302DQ38191990-0BC856CE-FF7B-475A-8C49-3C399F98EDE0Q38199495-8B73245E-9D0D-4399-B099-5191F30C5972Q38233871-BBF34722-739A-4DF0-82B6-9C85424B0F44Q38280403-DFFF7121-E5C0-4B69-BDFE-3819D7DD4C55Q38604232-E96DA062-65E9-41ED-A7C0-C4EA7A659E7CQ38733770-029C709D-ED7A-43C0-BA94-553C66B74958Q38938405-0C906CF9-0359-4A09-81C9-813D980B8258Q38973851-96A988FB-84F3-4289-83AD-5C2766B453C6Q39013242-0DA1A408-D680-43F3-9AF5-7100D08F3032Q39125521-9A765590-B137-428F-83D7-8F33E09D323BQ39200589-303EA2C0-AA53-4C73-A80B-236037857EF5Q40063703-7B4DC18B-E46C-4FF1-91F8-E6D232DB4B08Q41934973-D5579FFD-CC48-4EE3-8638-7727AA4DE67AQ42852792-76A57EB9-C0E9-417C-9E0C-2038B09115ECQ43530631-0B7E1298-B9D8-4213-9E79-71A570DF1EF2Q43699298-8F694B22-193E-425E-96A3-4280230A6AB0Q44010065-EF5A3A27-B740-4782-9513-A35DD541112AQ44046441-F143F1B3-1F63-4951-8DA0-8945A54C48E3Q44057851-67347BC4-AF48-4ACA-A0F6-EEA75C3D4CC9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Pierfrancesco Franco
@ast
Pierfrancesco Franco
@en
Pierfrancesco Franco
@es
Pierfrancesco Franco
@sl
type
label
Pierfrancesco Franco
@ast
Pierfrancesco Franco
@en
Pierfrancesco Franco
@es
Pierfrancesco Franco
@sl
prefLabel
Pierfrancesco Franco
@ast
Pierfrancesco Franco
@en
Pierfrancesco Franco
@es
Pierfrancesco Franco
@sl
P106
P1153
13906421300
P21
P214
505144782722616461860
P31
P496
0000-0003-2276-0687
P734
P735
P7859
viaf-505144782722616461860